Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erdosteine for Acute Rhinosinusitis
KCT0004649Phase 4Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of erdosteine in acute rhinosinusitis (ARS), sponsored by Daewoong Pharmaceutical. Started Oct 2019; status: completed.
02
Drugs
erdosteine
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on KCT0004649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004649.